Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/194952
Full metadata record
DC FieldValueLanguage
dc.contributor.authorÁlvarez, Josep-
dc.contributor.authorGodoy i García, Pere-
dc.contributor.authorPlans Rubio, Pedro-
dc.contributor.authorCamps, Neus-
dc.contributor.authorCarol, Mónica-
dc.contributor.authorCarmona i Parcerisa, Glòria-
dc.contributor.authorSolano, Rubén-
dc.contributor.authorRius, Cristina-
dc.contributor.authorMinguell, Sofía-
dc.contributor.authorBarrabeig i Fabregat, Irene-
dc.contributor.authorSala Farré, Maria Rosa-
dc.contributor.authorRodríguez, Raquel-
dc.contributor.authorGarcia Cenoz, Manuel-
dc.contributor.authorMuñoz Almagro, Carmen-
dc.contributor.authorDomínguez García, Àngela-
dc.contributor.authorTransmission of Pertussis in Households Working Group-
dc.date.accessioned2023-03-09T16:13:47Z-
dc.date.available2023-03-09T16:13:47Z-
dc.date.issued2020-11-01-
dc.identifier.issn1080-6040-
dc.identifier.urihttp://hdl.handle.net/2445/194952-
dc.description.abstractWe retrospectively assessed the effectiveness of azithromycin in preventing transmission of pertussis to a patient's household contacts. We also considered the duration between symptom onset in the primary patient and azithromycin administration. We categorized contacts into 4 groups: those treated within <7 days, 8-14 days, 15-21 days, and >21 days after illness onset in the primary patient. We studied 476 primary index patients and their 1,975 household contacts, of whom 4.5% were later identified as having pertussis. When contacts started chemoprophylaxis within <21 days after the primary patient's symptom onset, the treatment was 43.9% effective. Chemoprophylaxis started >14 days after primary patient's symptom onset was less effective. We recommend that contacts of persons with pertussis begin chemoprophylaxis within <14 days after primary patient's symptom onset.-
dc.format.extent7 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherCenters for Disease Control and Prevention-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3201/eid2611.181418-
dc.relation.ispartofEmerging Infectious Diseases, 2020, vol. 26, num. 11, p. 2678-2684-
dc.relation.urihttps://doi.org/10.3201/eid2611.181418-
dc.rightsDomini públic / Public domain-
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/*
dc.sourceArticles publicats en revistes (Medicina)-
dc.subject.classificationTos ferina-
dc.subject.classificationTerapèutica-
dc.subject.otherWhooping cough-
dc.subject.otherTherapeutics-
dc.titleAzithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012-2013-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec705180-
dc.date.updated2023-03-09T16:13:47Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
705180.pdf1.3 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons